InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Mary Reumuth, CHIEF FINANCIAL OFFICER, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 13 open-market SEC Form 4 transactions: 0 purchases worth $0 and 13 sales worth $129K, reported from Oct 26, 21 to Oct 23, 25. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 23, 25 | KALAKALA BIO, Inc. | SELL | 967 | $0.82 | $793 |
| Oct 22, 25 | KALAKALA BIO, Inc. | SELL | 32.2K | $0.83 | $27K |
| Jun 24, 25 | KALAKALA BIO, Inc. | SELL | 3.6K | $4.01 | $15K |
| Jun 3, 25 | KALAKALA BIO, Inc. | SELL | 2.9K | $3.74 | $11K |
| Jan 6, 25 | KALAKALA BIO, Inc. | SELL | 1.7K | $7.63 | $13K |
| Jun 26, 24 | KALAKALA BIO, Inc. | SELL | 4.2K | $4.75 | $20K |
| May 31, 24 | KALAKALA BIO, Inc. | SELL | 1.8K | $6.09 | $11K |
| Jan 4, 24 | KALAKALA BIO, Inc. | SELL | 1.2K | $6.74 | $8K |
| Jan 4, 23 | KALAKala Pharmaceuticals, Inc. | SELL | 60 | $28.54 | $2K |
| Oct 26, 22 | KALAKala Pharmaceuticals, Inc. | SELL | 194 | $6.51 | $1K |
| Jun 27, 22 | KALAKala Pharmaceuticals, Inc. | SELL | 2.6K | $0.37 | $967 |
| Jan 4, 22 | KALAKala Pharmaceuticals, Inc. | SELL | 2.9K | $1.30 | $4K |
| Oct 26, 21 | KALAKala Pharmaceuticals, Inc. | SELL | 9.4K | $1.80 | $17K |